01 1AURORE PHARMACEUTICALS PRIVATE LIMITED
02 1AX Pharmaceutical Corp
03 1Assia Chemical Industries Ltd - Teva Tech Site
04 1Aurobindo Pharma Limited
05 3Chromo Laboratories India Private Limited
06 2Dipharma Francis Srl
07 1Pharma Source Direct, Inc.
08 1SYMED LABS LIMITED
01 1MODAFINIL
02 10Modafinil
01 6India
02 1Israel
03 2Italy
04 1U.S.A
05 1Blank
NDC Package Code : 63415-0036
Start Marketing Date : 2019-08-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-576
Start Marketing Date : 2023-11-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72761-023
Start Marketing Date : 2019-08-05
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-023
Start Marketing Date : 2025-04-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-023
Start Marketing Date : 2021-09-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-023
Start Marketing Date : 2025-04-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0655
Start Marketing Date : 2018-08-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0102
Start Marketing Date : 2018-08-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0208
Start Marketing Date : 2023-10-14
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73377-314
Start Marketing Date : 2025-03-25
End Marketing Date : 2029-10-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
71
PharmaCompass offers a list of Modafinil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Modafinil manufacturer or Modafinil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Modafinil manufacturer or Modafinil supplier.
A Vigicer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vigicer, including repackagers and relabelers. The FDA regulates Vigicer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vigicer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vigicer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Vigicer supplier is an individual or a company that provides Vigicer active pharmaceutical ingredient (API) or Vigicer finished formulations upon request. The Vigicer suppliers may include Vigicer API manufacturers, exporters, distributors and traders.
click here to find a list of Vigicer suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vigicer as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vigicer API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vigicer as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vigicer and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vigicer NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vigicer suppliers with NDC on PharmaCompass.
We have 7 companies offering Vigicer
Get in contact with the supplier of your choice:
